Dr. Bateman answers IOM questions from the community: Part 1
Clark Ellis brings us Part 1 of an interview with Dr. Lucinda Bateman, where she answered questions posed by the patient community ...
Discuss the article on the Forums.

PGC-1alpha and TFEB provide two new therapeutic targets for Huntington's disease

Discussion in 'Other Health News and Research' started by Marco, Aug 13, 2012.

  1. Marco

    Marco Old blackguard

    Messages:
    1,649
    Likes:
    1,421
    Near Cognac, France
    I've posted before on the potential importance of the mitochondria stimulating PGC1-alpha pathway before in general bio-energetics terms. Not so much from the perspective of neuroprotection.

    Its importance may go well beyond 'fatigue' and exercise tolerance :


    My bold.

    http://www.news-medical.net/news/20...rapeutic-targets-for-Huntingtons-disease.aspx
     

See more popular forum discussions.

Share This Page